Dual Targeting of EZH2 Degradation and EGFR/HER2 Inhibition for Enhanced Efficacy against Burkitt’s Lymphoma

por Kim, Se Been, Yang, Chae-Eun, Jeong, Yurim, Yu, Minseo, Choi, Wan-Su, Lim, Jung-Yeon, Jeon, Youngwoo
Publicado 2023

Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt’s lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib

por Jeong, Yurim, Kim, Se Been, Yang, Chae-Eun, Yu, Min Seo, Choi, Wan-Su, Jeon, Youngwoo, Lim, Jung-Yeon
Publicado 2023